参考文献/References:
[1]黄天舒,裴丽鹏.miR-135a靶向PTEN促进宫颈癌细胞增殖、凋亡和转移能力的机制研究[J].解放军医药杂志,2021,33(1):20-26.[2]Arbyn M,Weiderpass E,Bruni L,et al.Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis[J].Lancet Glob Health,2020,8(2):e191-e203.[3]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[4]陈晓雯,姜李媛,陈亚,等.2015-2019年杭州地区农村妇女宫颈癌筛查情况分析[J].中国妇幼保健,2022,37(23):4460-4463.[5]窦倩如,黄翠敏,曹霞,等.2019-2022年海南省女性高危型人乳头瘤病毒感染及宫颈癌和癌前病变筛查报告[J].中华医院感染学杂志,2024,34(8):1210-1216.[6]张凤珍,朱丽秀,宋玮婷,等.宁德市2009-2018年农村妇女宫颈癌筛查结果分析[J].中国妇幼卫生杂志,2021,12(2):17-21.[7]赵东丽,杨慧,张永东,等.内蒙古准格尔旗宫颈癌筛查结果分析[J].内蒙古医学杂志,2021,53(8):965-967.[8]朱晶,杨菊,毕兵.自贡地区女性高危型人乳头状瘤病毒流行病学特征分析[J].安徽医药,2021,25(7):1376-1379.[9]Ma X,Wang Q,Ong JJ,et al.Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis[J].Sex Transm Infect,2018,94(6):434-442.[10]刘玉,韦艳,杨萍.2019年和2020年新疆石河子城区宫颈癌筛查结果对比研究[J].中国全科医学,2022,25(18):2223-2230.[11]Wang M,Hou B,Wang X,et al.Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage[J].Cancer Med,2021,10(7):2482-2488.[12]韦梦娜,余艳琴,徐慧芳,等.中国大陆地区不同宫颈病变人群中人乳头瘤病毒感染率及型别分布的系统研究[J].中国肿瘤临床与康复,2020,27(2):133-137.[13]潘丽,程铖,王春萍,等.2015-2020年兰州市妇女宫颈癌筛查结果分析[J].中国初级卫生保健,2022,36(11):77-80.[14]易立岩,韩丹,姜停停,等.2015-2020年吉林省宫颈癌筛查结果分析[J].中国妇幼卫生杂志,2022,13(3):33-37.[15]朱丽均,李力,彭艾平,等.84162名上海农村妇女宫颈癌筛查研究[J].中国肿瘤,2022,31(5):361-366.[16]贾小平.宫颈HPV感染调查和相关分子标志物在宫颈癌筛查中的研究[D].乌鲁木齐:新疆医科大学,2023.[17]徐奎,杨根荣.人乳头瘤病毒基因分型检测对宫颈癌前病变的筛查效能研究[J].实用医技杂志,2024,31(1):19-23.[18]林慧,陈佳菁,陈燕红,等.高危型HPV检测和TCT在宫颈癌前病变筛查中的应用价值[J].福建医药杂志,2022,44(5):21-24.[19]薛鹏.人工智能技术在宫颈癌筛查、分流和诊断中的应用研究[D].北京:北京协和医学院,2023.[19]Landau MS,Pantanowitz L.Artificial intelligence in cytopathology: a review of the literature and overview of commercial landscape[J].J Am Soc Cytopathol,2019,8(4):230-241.[20]张小松,杜芸,董燕,等.《人工智能辅助宫颈细胞学诊断技术的应用及质量控制专家共识》解读[J].中国妇幼健康研究,2024,35(3):1-4.[21]宋祎凡,刘晓雪,尹遵栋,等.2018-2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率[J].中国疫苗和免疫,2021,27(5):570-575.
相似文献/References:
[1]董 艳.重组人干扰素α2b阴道泡腾胶囊治疗
宫颈人乳头瘤病毒感染的临床研究[J].医学信息,2018,31(14):147.[doi:10.3969/j.issn.1006-1959.2018.14.045]
DONG Yan.Clinical Study of Recombinant Human Interferon α2b Vaginal Effervescent Capsule in the Treatment of Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(07):147.[doi:10.3969/j.issn.1006-1959.2018.14.045]
[2]李成诚,李 珣,李 明,等.宫颈HPV感染治疗现状[J].医学信息,2018,31(19):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]
LI Cheng-cheng,LI Xun,LI Ming,et al.Current Status of Treatment of Cervical HPV Infection[J].Journal of Medical Information,2018,31(07):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]
[3]NEELAM SAH,聂小凤,张 琴,等.宫颈脱落细胞miR-125b与宫颈病变关系及其在HR-HPV
阳性患者分层筛查中的作用研究[J].医学信息,2018,31(23):76.[doi:10.3969/j.issn.1006-1959.2018.23.021]
NEELAM SAH,NIE Xiao-feng,ZHANG Qin,et al.The Relationship between Cervical Exfoliated Cell miR-125b and Cervical Lesions and its Role in Stratified Screening of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(07):76.[doi:10.3969/j.issn.1006-1959.2018.23.021]
[4]唐菁娟.佛山和广州女性宫颈细胞HPV基因分型分析[J].医学信息,2019,32(12):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
TANG Jing-juan.HPV Genotyping Analysis of Female Cervical Cells in Foshan and Guangzhou[J].Journal of Medical Information,2019,32(07):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
[5]涂 琴,李 凌.自取样HPV检查在宫颈癌筛查中的应用[J].医学信息,2020,33(22):65.[doi:10.3969/j.issn.1006-1959.2020.22.020]
TU Qin,LI Ling.Analysis of the Effect of Self-sampling HPV Test in Cervical Cancer Screening[J].Journal of Medical Information,2020,33(07):65.[doi:10.3969/j.issn.1006-1959.2020.22.020]
[6]叶恬恬,张 婷,曹陈鑫,等.基于文献可视化分析中医药治疗HPV感染的研究热点及趋势[J].医学信息,2024,37(07):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]
YE Tian-tian,ZHANG Ting,CAO Chen-xin,et al.Research Hotspots and Trends of Traditional Chinese Medicine in the Treatment of HPV Infection Based on Literature Visualization[J].Journal of Medical Information,2024,37(07):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]